SCIENCE OF GLOBAL PROSTATE CANCER DISPARITIES

项目总结 前列腺癌是全球第二常见的男性癌症，也是最常见的男性癌症。 在非洲、加勒比海、欧洲和北美洲。虽然所有黑人男性都受到不成比例的 CAP、非裔美国人和牙买加男性的CAP比率被认为是世界上最高的。至 更好地理解和有效地解决黑人男性不成比例的帽子负担，重要的是 出于以下原因，在全球范围内探索黑人男性中的CAP：[1]黑人之间的祖先联系， 尤其是与跨大西洋奴隶贸易有关的那些；以及[2]关于奴隶贸易的文献越来越多 加勒比、欧洲和西部西非血统的黑人男性对帽子的负担不成比例 非洲。两年一度的全球前列腺癌黑人差异科学会议继续举行 为世界各地的CAP科学家、临床医生、倡导者和幸存者提供聚集的机会 以解决全球黑人男性戴帽子的负担。 第四届两年一度的会议独特地聚焦于在征服黑人男性前列腺癌方面取得进展 通过探索精准医学时代的个性化癌症护理。议程经过了独特的设计 促进所有代表之间的有效互动，并教育和便利立即传播 向幸存者和倡导者传递科学知识。会议将在奥兰多的诺纳湖医疗城举行， 因为佛罗里达州的上限负担很大。此外，该位置还提供了极好的设施 会议和旅游。大会将于2016年11月9日至12日举行。会议的主要主持人 是佛罗里达大学，由前列腺癌跨大西洋联盟(CAPTC)共同赞助， 非洲-加勒比癌症联盟(AC3)和非洲人后裔和前列腺癌 (狂人)财团。通过其他几个国家和国际机构提供了重要的协作支持 组织，包括：非洲癌症研究和培训组织，佛罗里达州中部 药房委员会(CFPC)和黑人男性前列腺癌联盟。

PROJECT SUMMARY Prostate cancer (CaP) is the second most common cancer in men globally and the most common male cancer in Africa, the Caribbean, Europe, and North America. While all Black men are disproportionately affected by CaP, African American and Jamaican men have been noted to have the highest rate of CaP in the world. To better understand and effectively address the disproportionate burden of CaP in Black men, it is important to explore CaP among Black men globally for the following reasons: [1] the ancestral link among Black men, especially those connected by the Transatlantic Slave Trade; and [2] the growing literature on the disproportionate burden of CaP among Black men of West African ancestry in the Caribbean, Europe, and West Africa. The Biennial Science of Global Prostate Cancer Disparities in Black Men Conference continues to provide opportunity for CaP scientists, clinicians, advocates, and survivors all over the world to come together to address the global burden of CaP among Black men. The 4th biennial conference uniquely focuses on making progress in conquering prostate cancer in Black men by exploring personalized cancer care in the era of precision medicine. The agenda has been uniquely designed to foster effective interactions among all delegates, and to educate, and to facilitate immediate dissemination of the science to survivors and advocates. The conference will take place in Lake Nona Medical City, Orlando, Florida because of the significant burden of CaP in Florida. In addition, the location offers excellent facilities for meetings and tourism. The conference will be held November 9-12, 2016. The primary host for the conference is the University of Florida, with co-sponsorship by the Prostate Cancer Transatlantic Consortium (CaPTC), African-Caribbean Cancer Consortium (AC3) and Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium. There is significant collaborative support through several other national and international organizations, including the: African Organization for Research and Training in Cancer (AORTIC), Central Florida Pharmacy Council (CFPC), and the Black Male Prostate Cancer Coalition.